Home > Media > Press releases

Press releases

  • Cellectis plant sciences announces the signature of a strategic partnership with SESVanderHave in Sugar Beet
    31 Jan 2012
    Subsidiaries
    ShareThis
    application/pdf icon
    120124_Cellectis_SESVanderHave_en.pdf
  • Changes in the Group's Scientific Division and appointment of the CEO of Cellectis Plant Sciences
    30 Jan 2012
    Corporate
    ShareThis
    application/pdf icon
    01302012_PR_Appointments.pdf
  • Medicago and Cellectis Enter into Research Agreement to Improve Therapeutic Proteins Using Nuclease Technology
    16 Jan 2012
    Subsidiaries
    ShareThis
    application/pdf icon
    PR_Medicago_Cellectis_120116.pdf
  • Cellartis is partner in InnovaLiv, a major multinational regenerative medicine project funded by the European Commission
    12 Jan 2012
    Subsidiaries
    ShareThis
    application/pdf icon
    120110 InnovaLiv_web.pdf
  • Cellectis launches a partnership with Total for exploratory research into microalgae-based substitutes for oil products
    09 Jan 2012
    Corporate
    ShareThis
    application/pdf icon
    120104 CP_Total_finale_E.pdf
  • Cellectis plant sciences and Bayer CropScience strengthen genome engineering partnership
    03 Jan 2012
    Subsidiaries
    ShareThis
    application/pdf icon
    CPS_Press Release_Bayer_Cropscience_EN.pdf
  • Cellectis bioresearch and Syngene announce partnership on the development of customized cell lines
    08 Dec 2011
    Subsidiaries
    ShareThis
    application/pdf icon
    Syngene and Cellectis Bioresearch_120111 final VE.pdf
  • Cellectis signs a license agreement under patents covering uses of homologous recombination with global pharmaceutical company
    05 Dec 2011
    ShareThis
    application/pdf icon
    CP_CLS Novartis-120511_E.pdf
  • Cellectis announces the final completion of the acquisition of Cellartis and €50 million financing round reserved for the FSI and Mr. Pierre Bastid.
    04 Nov 2011
    Corporate
    ShareThis
  • Cellectis shareholders approve the acquisition of Cellartis. Cellectis decides to raise €50 million from the FSI and Mr. Pierre Bastid, and to grant free share purchase warrants to all existing shareholders.
    02 Nov 2011
    Corporate
    ShareThis
    • X

    Enter your email address:

    Delivered by FeedBurner